BRCA 1 or 2 gene mutation, bilateral prophylactic mastectomy, direct breast reconstruction, surveillance, health related quality of life bilaterale profylactische mastectomie, directe borst reconstructie, BRCA 1 of 2 genmutatie, gezondheid gerelateerde kwaliteit van leven
Conditions
Interventions
BRCA 1 or 2 gene mutation carries who choose breast surveillance or bilateral prophylactic mastectomy with immediate reconstruction.
Sponsors
Prof. dr. J.M. Hendriks
Head of Dept. of Surgery
Erasmus University Medical Center
Rg 226
P.O. 2040
3000 CA Rotterdam
(T) 010-7031206
Eligibility
Inclusion criteria
Inclusion criteria: 1) > 18 years 2) agreement with participation 3) adequate understanding of Dutch language
Exclusion criteria
Exclusion criteria: 1) no adequate understanding of Dutch language 2) time since surgery <1 year, 3) time in surveillance <1 year.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient reported outcome values considering different strategies in breast cancer prevention in woman with BRCA 1 or 2 mutations. Patients will be grouped according to the strategy performed, i.e. bilateral prophylactic mastectomy or breast surveillance. Values will be collected through the HADS and the BREAST-Q. | — |
Contacts
Public ContactL.B. Koppert,
Department of Surgery, Erasmus MC Cancer Institute PO Box 5201
Outcome results
None listed